CG Oncology stock initiated with buy rating and $75 target by H.C. Wainwright By Investing.com
[ad_1] © Reuters. On Wednesday, H.C. Wainwright initiated coverage on CG Oncology (NASDAQ:CGON), issuing a Buy rating and setting a price target of $75.00. The...
MeridianLink stock target lifted at UBS on revised Q4 guidance By Investing.com
[ad_1] © Reuters. On Tuesday, UBS has raised the price target for MeridianLink (NYSE: MLNK) to $17.50, up from the previous target of $16.00, while...
Stratasys gets overweight rating with $24 stock target by Cantor Fitzgerald By Investing.com
[ad_1] © Stratasys PR On Tuesday, Cantor Fitzgerald initiated coverage of Stratasys Inc. (NASDAQ: NASDAQ:), a leader in 3D printing technology, with an Overweight rating...
Eli Lilly shares stock target raised to $853 by Jefferies By Investing.com
[ad_1] © Reuters. On Tuesday, Jefferies maintained a Buy rating on Eli Lilly (NYSE:) shares and increased the price target to $853 from the previous...
BMO raises HubSpot price target to $710 on growth outlook By Investing.com
[ad_1] © Reuters. On Monday, BMO Capital Markets updated its outlook on HubSpot Inc (NYSE:) by increasing the price target to $710 from the previous...
Citi sets Rocket Lab Buy rating with $6 price target By Investing.com
[ad_1] © Reuters. On Monday, Citi reinstated coverage on Rocket Lab USA (NASDAQ:RKLB), issuing a Buy rating and establishing a price target of $6.00. The...
CFRA cuts Neste Oyj stock rating to hold, slashes price target By Investing.com
[ad_1] © Reuters. On Friday, CFRA downgraded shares of Neste Oyj (NESTE:FH) (OTC: NTOIY) from a Strong Buy to a Hold, significantly reducing the price...
Motorola reports robust FQ4 earnings, analysts raise price target By Investing.com
[ad_1] © Reuters. Motorola (MSI) reports robust FQ4 earnings, analyst raises price target Motorola Solutions (NYSE:) reported better-than-anticipated earnings for the fiscal fourth quarter, but...
West Pharmaceutical upgraded to buy, price target jumps to $536 By Investing.com
[ad_1] © Reuters. On Wednesday, West Pharmaceutical Services Inc . (NYSE:) received an upgrade from a Jefferies analyst, elevating the stock’s status from Hold to...
Jefferies sets Eli Lilly price target to $814 By Investing.com
[ad_1] © Reuters. On Wednesday, Eli Lilly (NYSE:) received an increased price target from an analyst at Jefferies, now set at $814.00, up from the...